Documented in an LDA filing dated Jul 20, 2026
Sourced institutional rolesLDA lobbying records
ANDREW USYK
ANDREW USYK appears as a registered lobbyist in federal Lobbying Disclosure Act records connected to organizations tracked by Paper Trail.
Data updated Nov 1, 2026
Source-backed chronology
Career Timeline
Documented in an LDA filing dated Jan 15, 2026
Registered lobbyist
Inspect source ↗Prior government service disclosed in an LDA filing; exact dates not reported
Leg Assistant, Sen. Robert Casey; Legislative Aide, Sen. Kristen Gillibrand; Legislative Correspondent, Sen. Kristen Gillibrand; Compliance Officer, Sen. Gillibrand; Intern, Sen. Gillibrand and Rep. John Dingell
Federal government
Inspect source ↗Documented career transitions
Revolving Door
Congress → Lobbying
Federal governmentLeg Assistant, Sen. Robert Casey; Legislative Aide, Sen. Kristen Gillibrand; Legislative Correspondent, Sen. Kristen Gillibrand; Compliance Officer, Sen. Gillibrand; Intern, Sen. Gillibrand and Rep. John Dingell↓CencoraRegistered lobbyistCongress → Lobbying
Federal governmentLeg Assistant, Sen. Robert Casey; Legislative Aide, Sen. Kristen Gillibrand; Legislative Correspondent, Sen. Kristen Gillibrand; Compliance Officer, Sen. Gillibrand; Intern, Sen. Gillibrand and Rep. John Dingell↓Palantir TechnologiesRegistered lobbyistFederal LDA filings
Lobbying Activity
CENCORA, INC.1st Quarter (Jan 1 - Mar 31) 2026
Registrant: BROWNSTEIN HYATT FARBER SCHRECK, LLP · Health Issues
IRA implementation. Drug Shortages; supply chain resiliency; PAHPA Reauthorization; Drug Supply Chain Security Act (DSCSA) Implementation, SUPPORT Act Reauthorization, Appropriations bills (FDA, Labor, HHS).
LDA filing ↗CENCORA, INC.2nd Quarter (Apr 1 - June 30) 2026
Registrant: BROWNSTEIN HYATT FARBER SCHRECK, LLP · Health Issues
Drug Shortages; supply chain resiliency; PAHPA Reauthorization; Drug Supply Chain Security Act (DSCSA) Implementation, SUPPORT Act Reauthorization, Appropriations bills (FDA, Labor, HHS).
LDA filing ↗CENCORA, INC.2nd Quarter (Apr 1 - June 30) 2024
Registrant: BROWNSTEIN HYATT FARBER SCHRECK, LLP · Pharmacy
Recognizing pharmacists as providers within Medicare; The Equitable Community Access to Pharmacist Services Act (H.R.1770/S. 2477; Medicare reimbursement.
LDA filing ↗CENCORA, INC.2nd Quarter (Apr 1 - June 30) 2024
Registrant: BROWNSTEIN HYATT FARBER SCHRECK, LLP · Health Issues
IRA implementation. Drug Shortages; supply chain resiliency; PAHPA Reauthorization; Drug Supply Chain Security Act (DSCSA) Implementation, SUPPORT Act Reauthorization, National Defense Authorization Act. Appropriations bills (FDA, Labor, HHS).
LDA filing ↗PALANTIR TECHNOLOGIES INC.2nd Quarter (Apr 1 - June 30) 2026
Registrant: BROWNSTEIN HYATT FARBER SCHRECK, LLP · Science/Technology
Government programs relating to artificial intelligence
LDA filing ↗CENCORA, INC.4th Quarter (Oct 1 - Dec 31) 2025
Registrant: BROWNSTEIN HYATT FARBER SCHRECK, LLP · Health Issues
IRA implementation. Drug Shortages; supply chain resiliency; PAHPA Reauthorization; Drug Supply Chain Security Act (DSCSA) Implementation, SUPPORT Act Reauthorization, Appropriations bills (FDA, Labor, HHS).
LDA filing ↗